Quarterly Report • Nov 5, 2025
Quarterly Report
Open in ViewerOpens in native device viewer


Introduction
Adjusted EBITA, which excludes items affecting comparability, amounted to SEK 1,188 million (1,028), representing a margin of 10.0 per cent (9.7).
Items affecting comparability amounted to SEK –60 million and pertained to transaction and integration costs related to the acquisition of Validia in Finland.
| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
∆% | 2025 Jan–Sep |
2024 Jan–Sep |
∆% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 4,114 | 3,555 | 16 | 11,846 | 10,558 | 12 | 15,483 | 14,195 |
| Adjusted EBITA* | 570 | 478 | 19 | 1,188 | 1,028 | 16 | 1,532 | 1,372 |
| Operating margin, adjusted EBITA (%)* | 13.9 | 13.4 | 10.0 | 9.7 | 9.9 | 9.7 | ||
| EBITA* | 565 | 478 | 18 | 1,128 | 1,028 | 10 | 1,472 | 1,372 |
| Operating margin, EBITA (%)* | 13.7 | 13.4 | 9.5 | 9.7 | 9.5 | 9.7 | ||
| Operating profit, EBIT | 539 | 455 | 18 | 1,077 | 958 | 12 | 1,397 | 1,278 |
| Operating margin, EBIT (%)* | 13.1 | 12.8 | 9.1 | 9.1 | 9.0 | 9.0 | ||
| Profit for the period | 322 | 266 | 21 | 535 | 471 | 14 | 684 | 620 |
| Earnings per share before dilution, SEK | 3.83 | 3.14 | 22 | 6.38 | 5.43 | 17 | 8.16 | 7.21 |
| Earnings per share after dilution, SEK | 3.82 | 3.13 | 22 | 6.37 | 5.42 | 17 | 8.14 | 7.20 |
| Cash conversion (%)* | 73.7 | 66.0 | 78.7 | 86.5 | 90.1 | 97.9 | ||
| Free cash flow* | 482 | 385 | 25 | 1,168 | 1,258 | –7 | 1,876 | 1,966 |
*Alternative performance measures. For reconciliation of financial statements to IFRS, see Note 8. For purpose and definition, see ambea.com/investor-relations/reports/key-financial-figures-definitions
Introduction........................................................ 2 Quality and sustainability.................................4 Reporting ............................................................ 7 Group...................................................................7 Nytida................................................................10 Vardaga ..............................................................11 Stendi.................................................................12 Validia ................................................................ 13 Altiden................................................................14 Klara and Lära.................................................... 15 Group financial statements .............................. 20 Parent Company financial statements ............. 24 Notes................................................................. 26 CEO statement:
**eare accelerating growth and creating value by www.meeting.more.people's needs for quality care, while continuing to deliver in line with our financial targets in the third quarter.
One important driver for the above is Validia in Finland, which once again this quarter has delivered good earnings through high occupancy and quality. We are concurrently moving forward and establishing operations in yet another segment in Finland through an acquisition in care for children and youth, a segment where we have extensive experience from the other Nordic countries. I would like to welcome all care receivers and employees to Ambea.
Making more acquisitions and the start-up of new care units enable us to keep building on a strong Nordic platform for continued growth and development. Care needs are increasing vigorously and Ambea is ready to support our customers with more quality care places.
Total sales growth amounted to 16 per cent, driven by increased occupancy, price adjustments and acquisitions.
In parallel, we are strengthening our pipeline through new contracts and future establishments, not least in Vardaga, where we continue to expand elderly care in Sweden to a greater extent than any other provider. We signed four new contracts for nursing homes in the Stockholm area during the guarter, corresponding to 320 new elderly care places. Growth also continues in Nytida, where we signed new contracts in the period for group homes in the Stockholm area and expanded one daily activity unit in Lund, adding a total of just over 30 care places.
Organic growth totalled 4 per cent and was driven mainly by our Swedish operations and by Altiden's
continued positive performance. Strong occupancy and improved earnings mean we are now ready to take the next step and accelerate growth in Denmark.
Nytida continues to work on adapting to the new Social Services Act and, as expected, the operating margin is rising toward a slightly higher level.
While Stendi had slightly lower and more fluctuation in occupancy year-on-year, it continued to deliver high quality care and good profitability. We adjust capacity locally to match demand.
The integration of Validia is progressing well and the business area is already clearly contributing to the Group's growth and earnings. In Sweden, bolt-on acquisitions are being rapidly integrated into operations and are contribute positively both to sales and to earnings. Together, they showcase our ability to identify and further develop quality operations.
Due to the company's strong financial position, the Board has decided to repurchase a maximum of 2.000,000 own shares until the Annual General Meeting
The National Board of Health and Welfare's Care Receiver Survey showed high quality and a continued high level of satisfaction among care receivers at Vardaga. The results are above the national average and are reported openly for each nursing home on Vardaga's website.
We are proud of the quality elderly care we provide and are ready to continue expanding the provision of care to meet welfare challenges.
The number of people aged 85 and older is rising rapidly at the same time as the proportion of people in employment is falling. Sweden alone needs to build thousands of new care places, yet in many municipalities expansion has stalled and queues are arowina.
The situation is already acute. Elderly people with
high care needs have to wait months for the support they are entitled to, which often means loneliness, anxiety and increased ill health.
For sufficient care to be provided to everyone, more municipalities must engage private providers and allow us to contribute in the areas that we know: developing, building and operating more nursing homes.
We have been investing in various labour market initiatives for ten years as part of efforts to meet the skills shortage and to allow more people the opportunity to enter working life.
In the last few years, around 150 people from Ukraine have found employment at Vardaga and Nytida. During the auarter, we celebrated the araduation of 25 of our Ukrainian employees as nursing assistants, having first trained as care assistants. The training, which has also included language training and practical training, is a collaboration with the Beredskapslyftet non-profit organisation and has been very successful. We now intend

For sufficient care to be provided to everyone, more municipalities must engage private providers and allow us to contribute in the areas that we know: developing, building and operating more nursing homes.
to repeat the success and are starting a new class with another 30 participants.
We shoulder our climate responsibility and we had our science-based emissions-reduction targets validated and approved by the Science Based Targets initiative (SBTi) during the quarter. With these targets, we are now making another important advance towards care that is sustainable in terms of people, society and the environment.
Our strong Nordic platform, growing operations and satisfied care receivers mean we are ready to support society in meeting the increasingly urgent care needs. I would like to convey my heartfelt appreciation to all our employees for the commitment and the care they provide on a daily basis!
Mark Jensen, President and CEO Ambea
Ambea AB (publ) Corp. Reg. No. 556468-4354
Interim report Q3 2025 | 3
Quality and sustainability
Our mission is to create enough safe and sustainable care for all. To achieve this, we have established a robust quality management system that permeates all areas of our operations. Our approach to quality management is based on our vision, our values and the skills of our employees. We also have clear systems and procedures to support this approach. The aim is that it should be easy for employees to do the right thing, and to spend their time on the right things - care that creates quality of life and value. We use a Quality Index to monitor our care units on a monthly basis. The index consists of eight selected quality and HR metrics that show us the status of each unit, and allow us to monitor our operations systematically. Validia has an established quality reporting system that has now been adapted to the Group's standard and comprises part of the Group-wide monitorina.
For sustainability issues, we work with an established Environmental, Social and Governance (ESG) framework that encompasses all of our sustainability practices and performance.
We are working actively to achieve climate-smart care. This means that we are working to reduce the carbon footprint of our food, consumables, premises and transportation. Since 2019, Ambea has reduced its climate emissions 44 per cent*. Our emissions-reduction targets have been approved by the Science Based
Targets initiative (SBTi), which means that from 2026, we will have a clear and validated plan to guide us in the climate transition.
Social sustainability is ingrained in our DNA. In this area, we are focused on quality, leadership, health and safety, diversity and inclusion, and on spreading knowledge and developing the skills of our own and the sector's employees.
Our operations are characterised by robust control, transparency and trust, based on compliance with internal and external regulations and procedures. We participate in public debate with our knowledge and use our size to influence society and our sector.
By working actively with quality and sustainability, we are contributing to social development and helping to future-proof care.
77
During the quarter, our science-based emissions-reduction targets were approved by the Science Based Targets initiative – another important advance toward care that is sustainable in terms of people, society and the environment.

* Tonnes of CO₂e per unit of revenue, excluding employee commuting.
Introduction Quality and sustainability Reporting

"Our thanks to everyone who has supported us along the way. From not understanding a word of Swedish to getting a job and even meeting new friends," says Lesia Sementsiv, one of the nursing assistant graduates.
25 of our Ukrainian employees graduated as nursing assistants during the quarter. The graduation ceremony was held at Vardaga Villa, Sarvträsk in Nacka and resulted from an initiative combining teaching at Komvux, language studies and practical training at Vardaga and Nytida.
In the last few years, we have employed around 150 people who have fled the war in Ukraine. Of these, 25 have now graduated as nursing assistants.
"Many newly arrived residents find language, the lack of a network and difficulties in having their skills recognised to be real obstacles. We want to lower thresholds and create pathways into working life at the same time as we secure the skills needed in the care sector," says Mark Jensen, President and CEO of Ambea.
Together with the Beredskapslyftet non-profit organisation, we have started a new class that gives approximately 30 Ukrainian employees the opportunity to train as nursing assistants.
Ambea's emissions-reduction targets have been approved by the Science Based Targets initiative (SBTi), confirming that they are in line with the Paris Agreement's 1.5°C target.

Since 2019, Ambea has reduced its climate emissions 44 per cent. The approved near-term targets entail
Ambea's commitment to reducing its GHG emissions in its own operations (scope 1 and 2) 58.8 per cent by 2034 and to reducing emissions in the value chain (scope 3) 63.8 per cent per million SEK of value added over the same period, calculated from the 2024 level.
The emissions-reduction targets encompass all markets where Ambea operates.

Vardaga Ekbacken was the first to receive Vardaga's new sustainability diploma, which promotes sustainable initiatives throughout the operations. The diploma is already established at Nytida and is now being gradually introduced in the Group.
In August, Stendi arranged the Dream Weekend (Drømmehelg) festival – Norway's first festival for children and youth with disabilities. For a period of two days, the Tusenfryd amusement park was filled with concerts, competitions and opportunities to meet celebrities. A total of 140 children and youth attended together with their families and caregivers free of charge.
"Even the simplest of desires can feel unattainable for many people with disabilities. We wanted to change that," says Turi Marie Aastveit, personal assistance advisor at Stendi.
Many of the festival's partners were presented with the Stendi Inclusion Award

by Ingvild Kristiansen, Managing Director, Stendi. The aim is to make Dream Weekend an annual tradition.
In the National Board of Health and Welfare's 2025 Care Receiver Survey, care receivers at Vardaga's nursing homes were highly satisfied with the care provided. The score for home care services also remains very high, with 86 per cent saying they are satisfied. The results play a key role in our improvement efforts and are used to further develop our operations. They are presented by nursing home on Vardaga's website.
SATISFACTION
79.6%
Average private/ municipal 79.1%
TREATMENT
92.9%
Average private/ municipal 92.2% ACTIVITIES
68.2%
Average private/ municipal 59.3%

| Target | Outcome Q3 2025 |
Outcome Q3 2024 |
Comments | |
|---|---|---|---|---|
| Ambea's Quality Index An aggregated score of eight quality and HR KPIs. Scale of 1–10 |
>7.50 | 7.68 | 7.50 | Year-on-year, Ambea's Quality Index rose to 7.68 from 7.50. Altiden accounted for the largest improvement, driven by several targeted quality initiatives. Vardaga and Nytida are also improving while Stendi continues to maintain stable high levels. The score also includes the Validia acquisition and the total comprises a weighted score for all business areas. |
| Partial report of Ambea's Quality Index | ||||
| 1 Perceived care Care receivers' view of our care and operations. Scale of 1–100 |
>87% | 88% | 89% | The score refers to a weighted average of the scores from the most recent customer surveys in each business area. No new survey has been conducted in Sweden, Norway or Denmark. The score has changed compared with the same period last year because we included Validia's latest scores in the measurement. Including all countries, we have noted a slight dip in the score. |
| 2 Employee satisfaction Employee satisfaction surveys are performed on a regular basis during the year to measure satisfaction and engagement. Scale of 0–100 |
>75 | 72 | 73 | The survey is conducted six times per year, with the most recent being in August 2025. Ambea continues to score at a consis tently high level, compared with the benchmark of 70. Validia participated in this survey for the first time. All business areas work systematically to identify objectives and focus areas, both at central and at local levels, alongside of active and continuous im provements in each individual unit. Structured employee listening is a critical factor for us – not only to promote motivation and participation among employees, but also because it directly strengthens the quality of the care we provide. |
| 3 Leadership Index The employees' view of leadership at Ambea. Scale of 0–100 |
>80 | 76 | 78 | The survey is performed twice annually in the form of an in-depth questionnaire where employees evaluate their line manager based on Ambea's prioritised leadership qualities. Validia participated for the first time, marking the start of an important develo pment process for the group. The score is based on an average of all individual responses to various leadership questions and is close to the same quarter last year's score albeit slightly lower. One priority is developing the quality of our leadership given that present and clear leadership is crucial for our employees. |
| 4 Recommendation of Ambea Whether the employee would recommend Ambea as an employer. eNPS scale –100 – +100 |
>+20 | +26* | +26 The survey is conducted twice per year, and the most recent was performed in the second quarter of 2025. We continue to listen to and translate employees' feedback into tangible measures, with a particular focus on leadership, career opportunities and skills development. The next survey will be performed in the fourth quarter, when Validia will also participate for the first time. |
|
| 5 Internal control Control and follow-up of compliance in the operations with the quality management system. Scale of 0–2 |
>1.85 | 1.87 | 1.86 | The scores are based on the self-assessments conducted by all operational units in all business areas. The survey is conducted twice annually. The most recent survey for Sweden, Norway and Denmark took place in the second quarter of 2025. For the first time, the third quarter results include Validia's latest survey, and with the inclusion of Finland we noted a slight increase from the same quarter last year. |
| 6 Improvement Index Improvement measures implemented and documented in operations. Scale of 0–10 |
>7.50 | 7.58 | 6.90 | The Improvement Index – which reflects the extent to which identified improvements are being implemented – remained stable for Ambea as a whole. Altiden posted a clear increase from the same quarter last year. Vardaga and Stendi have also scored higher on the Improvement Index. Nytida posted a small decrease from the same quarter last year. The score for the quarter is a weighted average for all business areas and included Validia for the first time. |
* Outcome is unchanged compared with the preceding quarter since no new survey was conducted during the quarter. The survey excludes Validia.
Reporting
Net sales rose 16 per cent to SEK 4,114 million (3,555). Organic growth was 4 per cent, acquired growth was 13 per cent, and the currency effect was −1 per cent.
Net sales in own management rose 19 per cent to SEK 3,334 million (2,803). The growth was largely due to the acquired Validia business area in Finland. Acquisitions in Nytida also contributed, as did increased occupancy in Vardaga.
Net sales in contract management amounted to SEK 742 million (702). The increased sales were attributable to newly started contracts in Vardaga and Nytida.
Net sales in competence and staffing solutions amounted to SEK 38 million (50). The decrease was attributable to challenges related to demand for services in Klara.
Adjusted EBITA rose 19 per cent to SEK 570 million (478). The earnings improvement was driven mainly by the acquired Validia business area, bolt-on acquisitions and higher occupancy levels for Vardaga and Nytida. Altiden also continued to improve earnings.
The adjusted EBITA margin was 13.9 per cent (13.4). EBITA rose 18 per cent to SEK 565 million (478). Items affecting comparability in the quarter amounted to SEK -5 million, which pertained to integration costs linked to the acquisition of Validia.
The EBITA margin was 13.7 per cent (13.4).
EBIT rose 18 per cent to SEK 539 million (455), representing a margin of 13.1 per cent (12.8).
Net financial expense for the quarter was SEK –126 million (–118). Of this amount, SEK –91 million (–80) pertained to interest on lease liabilities, SEK –41 million (–39) to interest and financial expenses/income, and SEK 6 million (0) to exchange rate fluctuations.
Tax expense for the period was SEK –91 million (–71), corresponding to an effective tax rate of 22 per cent (21).
Profit for the period totalled SEK 322 million (266), corresponding to earnings per share of SEK 3.83 (3.14) before dilution and SEK 3.82 (3.13) after dilution.
Free cash flow for the quarter amounted to SEK 482 million (385). Free cash flow, excluding IFRS 16 effects, amounted to SEK 167 million (112). The improvement in cash flow was mainly attributable to higher earnings.

Reporting
Net sales rose 12 per cent to SEK 11,846 million (10,558). Organic growth was 4 per cent, acquired growth was 9 per cent, and the currency/calendar effect was –1 per cent. The comparative period was positively impacted by the leap day.
Net sales in own management rose 15 per cent to SEK 9,512 million (8,271). The growth was largely due to the acquired business area in Finland – Validia. Acquisitions in Nytida also contributed, as did increased occupancy in Vardaga.
Net sales in contract management amounted to SEK 2,188 million (2,113). The increased sales were attributable to newly started contracts in Vardaga and Nytida, but were offset by contracts terminated in Stendi.
Net sales in competence and staffing solutions amounted to SEK 146 million (174). The decrease was attributable to challenges related to demand for several services in Klara.
Adjusted EBITA rose 16 per cent to SEK 1,188 million (1,028). The earnings improvement was driven by the acquired Validia business area together with a higher occupancy level in Vardaga and improved earnings in Altiden and Nytida.
The comparative period was positively impacted by the leap day.
The adjusted EBITA margin was 10.0 per cent (9.7). EBITA rose 10 per cent to SEK 1,128 million (1,028). Items affecting comparability in the period amounted to SEK –60 million, which pertained to transaction and integration costs linked to the acquisition of Validia.
The EBITA margin was 9.5 per cent (9.7).
EBIT rose 12 per cent to SEK 1,077 million (958) representing a margin of 9.1 per cent (9.1).
Net financial expense for the quarter was SEK –376 million (–352). Of this amount, SEK –264 million (–237) pertained to interest on lease liabilities, SEK –118 million (–112) to interest and financial expenses/income, and SEK 6 million (–2) to exchange rate fluctuations.
Tax expense for the period was SEK –166 million (–135), corresponding to an effective tax rate of 24 per cent (22), impacted by non-deductible acquisition costs of SEK 56 million.
Profit for the period totalled SEK 535 million (471), corresponding to earnings per share of SEK 6.38 (5.43) before dilution and SEK 6.37 (5.42) after dilution.
Free cash flow for the period totalled SEK 1,168 million (1,258). Free cash flow, excluding IFRS 16 effects, amounted to SEK 264 million (443). Cash flow was negatively impacted by two non-recurring items. These items pertained to the settlement of a provision from 2021 for a dispute in Norway and payments linked to the acquisition of Validia. In total, these items amounted to SEK 128 million.


| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| EBITDA* | 930 | 798 | 2,187 | 1,980 | 2,852 | 2,645 |
| Adjustment for non-cash items | −2 | −20 | −13 | −47 | −47 | −81 |
| Change in working capital | −240 | −238 | −377 | −177 | −93 | 107 |
| Cash flow from investments in fixed assets1 | −13 | −15 | −87 | −61 | −126 | −100 |
| Operating cash flow, including investments to increase capacity* | 675 | 525 | 1,710 | 1,695 | 2,586 | 2,571 |
| Net interest paid | −123 | −116 | −378 | −353 | −492 | −467 |
| Tax paid | −70 | −24 | −164 | −84 | −218 | −138 |
| Free cash flow* | 482 | 385 | 1,168 | 1,258 | 1,876 | 1,966 |
| Acquisitions of subsidiaries and investment in financial instruments | 2 | −24 | –1,175 | −96 | –1,337 | −258 |
| Cash flow from financing activities | –471 | –358 | 236 | –1,126 | –325 | –1,687 |
| Cash flow for the period | 13 | 3 | 229 | 37 | 213 | 21 |
| 1) of which sales of fixed assets | 15 | 1 | 16 | 13 | 20 | 17 |
| Operating cash flow, excluding IFRS 16 effects* | 269 | 172 | 542 | 643 | 1,061 | 1,162 |
| Free cash flow, excluding IFRS 16 effects* | 167 | 112 | 264 | 443 | 696 | 875 |
| Excl. IFRS 16 effects | Incl. IFRS 16 effects | |||||
|---|---|---|---|---|---|---|
| SEK million | 2025 30 Sep |
2024 30 Sep |
2024 31 Dec |
2025 30 Sep |
2024 30 Sep |
2024 31 Dec |
| Net interest-bearing debt* | 3,389 | 2,356 | 2,098 | 13,133 | 11,222 | 11,027 |
| Rolling 12 months adjusted EBITDA* | 1,392 | 1,178 | 1,237 | 2,912 | 2,571 | 2,645 |
| Net debt/Rolling 12-months adjusted EBITDA* | 2.4 | 2.0 | 1.7 | 4.5 | 4.4 | 4.2 |
| Excl. IFRS 16 effects | Incl. IFRS 16 effects | ||||
|---|---|---|---|---|---|
| 2025 | 2024 | 2024 | 2025 | 2024 | 2024 |
July–September 2025

July–September 2025

*Alternative performance measures. For reconciliation of financial statements to IFRS, purpose and definition see ambea.com/investor-relations/reports/key-financial-figures-definitions

Nytida provides support and care for children, youth and adults in the form of lifelong disability care and psychosocial support. We offer residential facilities, daily activity units, support for individuals and families, and schools for more than 5,000 care receivers in around 470 units across Sweden. Using proven models and in-depth knowledge, our employees help to strengthen the ability of individuals to live an independent life.
Nytida continued to post healthy growth together with strong earnings and margin improvements. During the quarter, a new care unit with six new care places was opened. At the same time, contracts were signed for three new care units with six care places each and the expansion of an existing care unit with 16 places is being planned, thereby strengthening the growth plan going forward. In parts of the operations, capacity was also adjusted to meet changing demand.
Net sales rose 9 per cent year-on-year to SEK 1,148 million (1,056). Net sales in own management amounted to SEK 923 million (850), up 9 per cent. The growth was driven by acquired and start-up units. Net sales in contract management amounted to SEK 225 million (206). The increase was linked to the positive net effect between start-up and terminated management contracts.
EBITA increased to SEK 194 million (168). The positive change was attributable to the continued good performance in previously completed acquisitions together with improved occupancy for start-up units. The new Social Services Act entered force on 1 July this year and has resulted in partial changes to the requirements municipalities have to comply with. We have continued adapting our service offering in favour of those with expected higher demand going forward. Accordingly, we have therefore restructured or closed a

number of operational units in the quarter, which has contributed positively to the earnings trend for the period.
The EBITA margin was 16.9 per cent (15.9).
Net sales rose 9 per cent year-on-year to SEK 3,420 million (3,141). Net sales in own management amounted to SEK 2,763 million (2,525). The increase was driven by acquired and start-up units.
Occupancy challenges in parts of the Individual and family care service offering offset the increase.
Net sales in contract management amounted to SEK 657 million (616). The increase was due mainly to a positive net effect between start-up and terminated management contracts together with price.
EBITA increased to SEK 439 million (417). The earnings improvement was attributable to start-up units and the good performance in previously completed acquisitions. The comparative period was positively impacted by calendar effects.
The EBITA margin was 12.8 per cent (13.3).
370
Number of care places opened under own management (RTM), where 314 arose from acquisitions and 56 from newly opened units.

| SEK million | 2025 Jul-Sep |
2024 Jul-Sep |
Δ% | 2025 Jan-Sep |
2024 Jan-Sep |
Δ% | RTM | 2024 Jan-Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 1,148 | 1,056 | 9 | 3,420 | 3,141 | 9 | 4,528 | 4,249 |
| EBITA* | 194 | 168 | 15 | 439 | 417 | 5 | 560 | 538 |
| Operating margin, EBITA (%)* |
16.9 | 15.9 | 12.8 | 13.3 | 12.4 | 12.7 |
* Alternative performance measures.

At Vardaga's over 100 nursing homes across Sweden, we offer elderly care where every day matters. We provide around 8,000 care receivers with expertise and safety in our nursing homes, and in home care. Our employees work to ensure quality of life and a sense of security for each individual.
Vardaga had an active quarter with continued positive growth and strong development in operations. Contracts were signed for four new nursing homes with a total of 320 care places in the quarter. In addition, a new nursing home was opened in Norrköping with 72 care places.
Net sales rose 7 per cent year-on-year to SEK 1,381 million (1,288). Net sales in own management amounted to SEK 952 million (882), up 8 per cent. The increase was due to higher occupancy in new and established nursing homes as well as a previously completed acquisition.
Net sales in contract management amounted to SEK 429 million (406), up 6 per cent. The increase was due to a positive net effect between start-up and terminated management contracts.
EBITA rose 10 per cent to SEK 177 million (161). The improved earnings were driven by higher occupancy.
The EBITA margin was 12.8 per cent (12.5).
Net sales rose 7 per cent year-on-year to SEK 4,052 million (3,781). Net sales in own management amounted to SEK 2,782 million (2,591), up 7 per cent. The increase was due to higher occupancy in new and established nursing homes.
Net sales in contract management amounted to SEK 1,270 million

(1,190), up 7 per cent. The increase was due to a positive net effect between start-up and terminated management contracts.
EBITA rose 9 per cent to SEK 403 million (369). Earnings were driven by increased occupancy. The comparative period was positively impacted by calendar effects.
The EBITA margin was 9.9 per cent (9.8).
320
Number of newly signed care places under own management in the quarter.

**Mature units do not include nursing homes under own management that were opened after G3 2023, or nursing homes that are not yet onen
| SEK million | 2025 Jul-Sep |
2024 Jul-Sep |
Δ% | 2025 Jan–Sep |
2024 Jan-Sep |
Δ% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 1,381 | 1,288 | 7 | 4,052 | 3,781 | 7 | 5,358 | 5,087 |
| EBITA* | 177 | 161 | 10 | 403 | 369 | 9 | 525 | 491 |
| Operating margin, EBITA (%)* | 12.8 | 12.5 | 9.9 | 9.8 | 9.8 | 9.7 | ||
| Operating margin, EBITA mature units (%)* | 14.3 | 14.1 | 11.4 | 11.2 | 11.1 | 11.0 |
* Alternative performance measures.
Stendi is the largest care provider in Norway and runs nationwide operations in disability and psychosocial care for adults, children and youth. We have about 850 care receivers and more than 300 units across Norway, and work every day to strengthen individuals and create quality of life.
During the quarter, Stendi opened two new care units and a total of five care places. In addition to the new openings, contracts have been signed for two new care units with a total of 11 care places.
Net sales decreased 3 per cent to SEK 818 million (841). Sales remained unchanged year-on-year in local currency. All operations in Stendi are conducted under own management.
The development in the quarter was attributable to lower and more fluctuating occupancy than in the strong comparative year, and was partly offset by a higher share of care receivers with high compensation.
EBITA was SEK 100 million (121). The decline in earnings was attributable to lower and more fluctuating occupancy, which could not be fully offset in the short term by lower personnel costs.
The EBITA margin was 12.2 per cent (14.4).
Net sales decreased 2 per cent to SEK 2,464 million (2,518). Sales rose 2 per cent in local currency.
Net sales in own management amounted to SEK 2,464 million (2,484). Sales rose 3 per cent in local currency.
The increase was driven by a change in the mix of services provided,

whereby care with higher compensation accounted for a larger share.
Net sales in contract management amounted to SEK 0 million (34). EBITA was SEK 197 million (241). Earnings for the period were impacted by lower and more fluctuating occupancy, which resulted in lower staffing efficiency.
The comparative period was positively impacted by an amount of SEK 4 million from property sales.
The EBITA margin was 8.0 per cent (9.6).
51
Number of care places under own management under construction.

| SEK million | 2025 Jul-Sep |
2024 Jul-Sep |
Δ% | 2025 Jan-Sep |
2024 Jan-Sep |
Δ% | RTM | 2024 Jan-Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 818 | 841 | -3 | 2,464 | 2,518 | -2 | 3,298 | 3,352 |
| EBITA* | 100 | 121 | -17 | 197 | 241 | -18 | 290 | 334 |
| Operating margin, EBITA (%)* |
12.2 | 14.4 | 8.0 | 9.6 | 8.8 | 10.0 |
* Alternative performance measures.
Validia is Ambea's Finnish business area and offers support. care and residential facilities for people with physical and intellectual disabilities, neurological injuries and psychosocial problems. Validia has approximately 50 units across Finland and more than 2,600 employees.
Validia is reporting its second augrter since the business area became part of Ambea on 1 April 2025. This means that comparative figures for the year-earlier period are unavailable. Validia posted another strong guarter both financially and operationally.
Validia's integration is proceeding as planned and took further steps forward in the guarter. The work is divided into a number of clearly defined areas, several of which have already been completed. We are working with focus and determination to create further growth in Validia through new establishments, bolt-on acquisitions and continued development of existing operations.
Net sales amounted to SEK 388 million. All operations in Validia are conducted under own management.
EBITA was SEK 59 million. Validia has continued to post strong earnings growth during the ongoing integration, in the seasonally strongest quarter.
The EBITA margin was 15.2 per cent.
After the guarter ended, Validia acquired the individual and family care operations of Attendo. The operations comprise five care units with 35 care places and foster care services for around 150 children and youth. In 2024, revenue amounted to SEK 90 million. The acquisition was completed on 31 October 2025.
Net sales amounted to SEK 763 million. All operations in Validia are

conducted under own management. EBITA was SEK 98 million. The EBITA margin was 12.8 per cent. Number of care places under own management under construction

| SEK million | 2025 Jul-Sep |
2024 Jul-Sep |
Δ% | 2025 Jan-Sep |
Δ% | |
|---|---|---|---|---|---|---|
| Net sales | 388 | - | - | 763 | - | - |
| EBITA* | 59 | - | - | 98 | - | - |
| Operating margin, EBITA (%)* | 15.2 | - | 12.8 | - |
*Alternative performance measures.
Altiden is the largest private care provider in Denmark, with about 50 operational units in elderly care, disability care and social care. We have about 750 care receivers. and work to ensure quality of life for each individual, with a focus on security and development.
Increased occupancy and the ongoing restructuring work resulted in another guarter with a clear improvement in earnings.
Net sales rose 7 per cent to SEK 341 million (320). Sales rose 10 per cent in local currency.
Net sales in own management amounted to SEK 253 million (230). Sales rose 13 per cent in local currency.
The increase was driven by higher occupancy both in social and in
Net sales in contract management amounted to SEK 88 million (90).
Sales rose 1 per cent in local currency.
EBITA was SEK 39 million (25). The positive change in earnings was due to the improved occupancy together with operational improve-
The EBITA margin was 11.4 per cent (7.8).
Net sales rose 6 per cent to SEK 1,001 million (944). Sales rose 9 per cent in local currency.
Net sales in own management amounted to SEK 740 million (672). Sales rose 13 per cent in local currency.
The increase was driven by higher occupancy both in social and in
Net sales in contract management amounted to SEK 261 million

(272). Sales declined 1 per cent in local currency. The decrease was due to lower occupancy for one expiring social care contract.
EBITA was SEK 48 million (3). The earnings increase was due to the improved occupancy together with operational improvements primarily in social care.
The EBITA margin was 4.8 per cent (0.3).
Number of care places in operation under own

| SEK million | 2025 Jul-Sep |
2024 Jul-Sep |
Δ% | 2025 Jan-Sep |
2024 Jan-Sep |
Δ% | RTM | 2024 Jan-Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 341 | 320 | 7 | 1,001 | 944 | 6 | 1,330 | 1,273 |
| EBITA* | 39 | 25 | 56 | 48 | 3 | - | 58 | 13 |
| Operating margin, EBITA (%)* |
11.4 | 7.8 | 4.8 | 0.3 | 4.4 | 1.0 |
*Alternative performance measures.
Klara is one of the leading providers of staffing solutions for schools and elderly and social care in Sweden, with a focus on staffing, mobile nursing teams and student health services.
Lära is one of the leading providers in Sweden in training and skills development for social work, care, healthcare, schools and therapy.
Net sales decreased 9 per cent to SEK 86 million (94). The decrease was due to weaker demand for several of Klara's services. A historically good supply of nurses has led some customers to employ their own staff instead of purchasing various services.
EBITA decreased to SEK 9 million (10). Klara has adjusted its cost base to the weaker demand and thereby been able to stabilise earnings.
The EBITA margin was 10.5 per cent (10.6).
Net sales decreased 4 per cent to SEK 290 million (303). The change was due to weaker demand in several service areas.
EBITA rose 8 per cent to SEK 26 million (24). Klara has adjusted its cost base to reflect structurally lower market demand, which resulted in a positive earnings trend.
The EBITA margin was 9.0 per cent (7.9).

9.3% EBITA amounted to
9.3 per cent (RTM).

| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
∆% | 2025 Jan–Sep |
2024 Jan–Sep |
∆% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 86 | 94 | −9 | 290 | 303 | −4 | 396 | 409 |
| EBITA* | 9 | 10 | −10 | 26 | 24 | 8 | 37 | 35 |
| Operating margin, EBITA (%)* |
10.5 | 10.6 | 9.0 | 7.9 | 9.3 | 8.6 |
* Alternative performance measures.

| SEK million | 2025 Q3 |
2025 Q2 |
2025 Q1 |
2024 Q4 |
2024 Q3 |
|---|---|---|---|---|---|
| Ambea | |||||
| Number of care places in operation under own management on the closing date |
11,740 | 11,726 | 10,227 | 10,241 | 9,991 |
| Number of care places opened under own management (RTM) | 164 | 107 | 282 | 268 | 322 |
| Number of care places under own management under construction |
1,621 | 1,360 | 1,285 | 1,308 | 1,283 |
| Confirmed management contract start-ups/terminations, SEK million* |
−51 | –107 | –8 | 31 | 140 |
| Nytida | |||||
| Number of care places in operation under own management | 5,434 | 5,488 | 5,420 | 5,427 | 5,174 |
| Number of care places opened under own management (RTM) | 56 | 65 | 89 | 60 | 61 |
| Number of care places under own management under con struction |
158 | 137 | 143 | 167 | 171 |
| Confirmed management contract start-ups/terminations, SEK million* |
2 | 4 | 20 | –3 | 44 |
| Vardaga | |||||
| Number of care places in operation under own management | 3,737 | 3,665 | 3,621 | 3,625 | 3,625 |
| Number of care places opened under own management (RTM) | 72 | – | 160 | 160 | 160 |
| Number of care places under own management under construction |
1,334 | 1,086 | 1,056 | 1,056 | 1,060 |
| Confirmed management contract start-ups/terminations, SEK million* |
−15 | –73 | 10 | 34 | 96 |
| SEK million | 2025 Q3 |
2025 Q2 |
2025 Q1 |
2024 Q4 |
2024 Q3 |
|---|---|---|---|---|---|
| Stendi | |||||
| Number of care places in operation under own management | 692 | 687 | 671 | 674 | 672 |
| Number of care places opened under own management (RTM) | 36 | 42 | 28 | 43 | 57 |
| Number of care places under own management under construction |
51 | 59 | 86 | 85 | 52 |
| Validia | |||||
| Number of care places in operation under own management | 1,373 | 1,372 | – | – | – |
| Number of care places opened under own management (RTM) | – | – | – | – | – |
| Number of care places under own management under construction |
78 | 78 | – | – | – |
| Altiden | |||||
| Number of care places in operation under own management | 504 | 514 | 515 | 515 | 520 |
| Number of care places opened under own management (RTM) | – | – | 5 | 5 | 44 |
| Number of care places under own management under construction |
– | – | – | – | – |
| Confirmed management contract start-ups/terminations, SEK million* |
–38 | –38 | –38 | – | – |
*Net of confirmed contract management start-ups/terminations in the coming 12 months. Adjustments have been made in Q3 2024.

Through the acquisition of the operations of Aleris Omsorg in 2019, Ambea has been party to an ongoing legal proceeding in Norway regarding costs for temporary care workers. Historically, Aleris had used a considerable number of consultants to staff some of its operations. Since the acquisition of Aleris, Ambea has been working actively to increase the proportion of permanent employees in the operations. In 2021, a judgment was handed down in favour of the temporary consultants, granting them the right to additional compensation for overtime, holidays and pension for the time they were engaged as consultants. A subsequent proceeding has been ongoing regarding the limitation periods for some of the compensation. In the fourth quarter of 2021, Ambea made a provision of SEK 145 million to cover estimated additional claims and legal costs. During the quarter, a large part of the previous provision (SEK 72 million) was settled. As of 30 September 2025, the current remaining provision for known and unknown claims amounted to SEK 15 million.
In 2018, Ambea received a reassessment notice from the Swedish Tax Agency regarding VAT of SEK 12 million, including tax surcharges but excluding interest, for prior years in Ambea AB (publ). No provision was made for these costs. The reassessment was mainly related to input VAT on costs arising from the IPO in 2017. The company appealed the Swedish Tax Agency's decision to the Administrative Court. The Administrative Court ruled in favour of the Swedish Tax Agency's decision, so Ambea appealed to a higher court in 2021. As of 30 September 2025, the tax dispute amounted to SEK 14 million, including interest.
During the quarter, there were no transactions between Ambea and related parties with any material impact on the company's position and earnings. The nature and volume of transactions remained unchanged during the period compared with the previous year.
Validia acquired the individual and family care operations of Attendo in Finland. The acquired operations posted revenue of SEK 90 million for 2024. The acquisition was completed on 31 October 2025 and encompassed five care units and foster care services for children and youth.
Ambea's Board has decided to buy back shares in accordance with the General Meeting's guidelines. The buyback comprises a maximum of 2 million shares before the next ordinary AGM.
After the end of the period, Ambea signed a new loan agreement with a consortium of three banks. The agreement has a three-year term with an option to extend for one + one year. The confirmed credit line is SEK 5 billion with the possibility to extend the line by a further SEK 1.5 billion (unconfirmed credit). The agreement replaces the existing loan agreement.
Ambea's operating profit is affected by seasonal variations, weekends and public holidays.
Weekends and public holidays reduce Ambea's profit ability due to higher personnel costs for inconvenient working hours. Most of the public holidays in countries where the company has operations normally fall in the second quarter. In some years, Easter may fall in the first quarter and then affect its profitability. Christmas and New Year affect the first and fourth quarters.
The company's personnel costs are affected in a
similar manner when employees take out their holidays. For example, the company is most profitable in the third quarter, as employees usually take their holidays during July and August and therefore receive holiday pay that is continuously accrued throughout the year. Costs during the summer months are also generally lower due to a reduced schedule for central activities, such as mandatory training programmes and central initiatives, during this period.
During the quarter, the average number of full-time employees (FTEs) was 17,862 (15,937), and the increase was due to acquired and start-up units.
The total number of shares was 84,101,290. Ambea holds no treasury shares. There was no change in the number of shares during the quarter.
Ambea is exposed to a variety of risks and attaches great importance to continuously analysing, minimising and managing these risks. The risk assessment is also a key element of the annual strategy process, where risks in relation to the company's ability to achieve its financial targets and strategic ambitions are specifically evaluated. Ambea has identified a number of risks in the categories of competitive risks, operational risks and risks associated with governance. For a description of the specific risks and how they are managed, refer to pages 50–52 of the 2024 Annual Report. The company's risks and uncertainties are deemed to be unchanged compared to those described in the 2024 Annual Report.
The content of this interim report was adopted on 4 November 2025.

Stockholm, 4 November 2025
Mark Jensen President and CEO
Ambea will hold a presentation for the financial market, with the possibility to participate by phone, at 10.00 a.m. CET on Wednesday, 5 November 2025. The presentation will be held in English, and available as a webcast at ambea.se or via Direct Link: edge.media-server.com/mmc/p/eg7ey76i
The quarterly report and related presentation will be available at ambea.com/investor-relations/reports/reports-and-presentations/
To join the conference call, register before the call using the number link below. When you register, you will receive a dial-in number and a unique dial-in PIN. To make sure your connection to the conference call works, please call ten minutes before the conference call is due to start.
register-conf.media-server.com/register/BI7190d745b61c408b8263befa746d0176
Susanne Vogt, Head of IR, Reporting & Group Business Control [email protected]
This information is such that Ambea AB (publ) is obliged to publish pursuant to the EU Market Abuse Regulation.
Ambea AB (publ), corporate identity number 556468-4354
We have reviewed the condensed interim report for Ambea AB (publ) as at September 30, 2025 and for the nine months period then ended. The Board of Directors and the Managing Director are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Swedish Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.
We conducted our review in accordance with the International Standard on Review Engagements, ISRE 2410 Review of Interim Financial Statements Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and other generally accepted auditing standards in Sweden.
The procedures performed in a review do not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the interim report is not prepared, in all material respects, in accordance with IAS 34 and the Swedish Annual Accounts Act regarding the Group, and in accordance with the Swedish Annual Accounts Act regarding the Parent Company.
Stockholm, November 4, 2025
Ernst & Young AB
Mikael Sjölander Authorized Public Accountant

| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating income | ||||||
| Net sales | 4,114 | 3,555 | 11,846 | 10,558 | 15,483 | 14,195 |
| Other operating income | 31 | 35 | 107 | 119 | 150 | 162 |
| Operating income | 4,145 | 3,590 | 11,953 | 10,677 | 15,633 | 14,357 |
| Operating expenses | ||||||
| Consumables | −144 | −124 | −405 | −363 | −534 | −492 |
| Other external costs | −377 | −318 | –1,141 | −999 | –1,474 | –1,332 |
| Personnel costs | –2,694 | –2,352 | –8,223 | –7,337 | –10,777 | –9,891 |
| Depreciation, amortisation and impairment | −392 | −343 | –1,110 | -1,022 | –1,455 | –1,367 |
| Other operating expenses | 1 | 2 | 3 | 2 | 4 | 3 |
| Operating expenses | –3,606 | –3,135 | –10,876 | –9,719 | –14,236 | –13,079 |
| Operating profit | 539 | 455 | 1,077 | 958 | 1,397 | 1,278 |
| Financial income | 6 | 0 | 6 | 0 | 6 | 0 |
| Financial expenses | −132 | −118 | −382 | −352 | −496 | −466 |
| Net financial items | −126 | −118 | −376 | −352 | −490 | −466 |
| Profit before tax | 413 | 337 | 701 | 606 | 907 | 812 |
| Tax on profit for the period | −91 | −71 | −166 | −135 | −223 | −192 |
| Profit for the period | 322 | 266 | 535 | 471 | 684 | 620 |
| Profit for the period attributable to shareholders of the Parent Company |
322 | 266 | 535 | 471 | 684 | 620 |
| Earnings per share before dilution, SEK | 3.83 | 3.14 | 6.38 | 5.43 | 8.16 | 7.21 |
| Earnings per share after dilution, SEK | 3.82 | 3.13 | 6.37 | 5.42 | 8.14 | 7.20 |
| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Profit for the period after tax | 322 | 266 | 535 | 471 | 684 | 620 |
| Other comprehensive income, items not transferable to profit or loss |
||||||
| Remeasurement of defined-benefit pension plans | – | −28 | 14 | −28 | 40 | −2 |
| Tax related to remeasurement of defined-benefit pension plans |
– | 6 | −3 | 6 | −9 | 0 |
| Total items not transferable to profit or loss | – | −22 | 11 | −22 | 31 | −2 |
| Other comprehensive income, items transferable to profit or loss |
||||||
| Translation differences | 12 | –41 | −14 | −23 | 2 | −7 |
| Hedging of net investments in foreign operations Cash flow hedges |
1 6 |
17 −9 |
18 −4 |
9 −7 |
12 4 |
3 1 |
| Cash flow hedge reserve | 1 | 2 | 1 | −16 | 3 | −14 |
| Remeasurement of tenant-owned apartments | – | – | – | – | 0 | 0 |
| Tax | −2 | 2 | −3 | 3 | −4 | 2 |
| Total items transferable to profit or loss | 18 | −29 | −2 | −34 | 17 | −15 |
| Total other comprehensive income | 18 | –51 | 9 | −56 | 48 | −17 |
| Total comprehensive income for the period | 340 | 215 | 544 | 415 | 732 | 603 |
| Comprehensive income for the period attributable to shareholders of the Parent Company |
340 | 215 | 544 | 415 | 732 | 603 |

| 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|
|---|---|---|---|---|---|---|
| Profit for the period attributable to shareholders of the Parent Company, SEK million |
322 | 266 | 535 | 471 | 684 | 620 |
| Earnings per share before dilution Average number of shares, thousand |
84,101 | 84,614 | 83,816 | 86,692 | 83,792 | 85,945 |
| Earnings per share before dilution, SEK | 3.83 | 3.14 | 6.38 | 5.43 | 8.16 | 7.21 |
| Earnings per share after dilution Average number of shares, thousand |
84,331 | 84,869 | 84,028 | 86,856 | 83,993 | 86,139 |
| Earnings per share after dilution, SEK | 3.82 | 3.13 | 6.37 | 5.42 | 8.14 | 7.20 |

| SEK million | 2025 30 Sep |
2024 30 Sep |
2024 31 Dec |
|---|---|---|---|
| Assets | |||
| Fixed assets | |||
| Goodwill | 8,328 | 7,057 | 7,211 |
| Customer contracts and customer relationships | 483 | 255 | 262 |
| Other intangible assets | 40 | 26 | 25 |
| Right-of-use assets | 9,248 | 8,442 | 8,496 |
| Tangible assets | 394 | 295 | 325 |
| Derivative instruments | 4 | – | 9 |
| Surplus in funded pension plans | 18 | – | 10 |
| Deferred tax assets | 220 | 150 | 179 |
| Non-current receivables | 154 | 132 | 132 |
| Total fixed assets | 18,889 | 16,357 | 16,649 |
| Current assets | |||
| Accounts receivable | 1,464 | 1,255 | 1,284 |
| Other receivables | 164 | 99 | 83 |
| Prepaid expenses and accrued income | 432 | 420 | 431 |
| Cash and cash equivalents | 259 | 45 | 28 |
| Total current assets | 2,319 | 1,819 | 1,826 |
| Total assets | 21,208 | 18,176 | 18,475 |
| SEK million | 2025 30 Sep |
2024 30 Sep |
2024 31 Dec |
|---|---|---|---|
| Equity and liabilities | |||
| Equity | |||
| Share capital | 2 | 2 | 2 |
| Other capital contributions | 6,212 | 6,175 | 6,198 |
| Reserves | −58 | −65 | −53 |
| Retained earnings, including profit for the year | –797 | –1,338 | –1,161 |
| Total equity | 5,359 | 4,774 | 4,986 |
| Non-current liabilities | |||
| Non-current interest-bearing liabilities | 2,522 | 1,643 | 1,087 |
| Lease liabilities | 8,428 | 7,761 | 7,791 |
| Derivative instruments | – | 1 | – |
| Other non-interest-bearing liabilities | 18 | 20 | 20 |
| Pension provisions | 0 | 22 | 10 |
| Other provisions | 8 | 84 | 12 |
| Deferred tax liabilities | 360 | 222 | 279 |
| Total non-current liabilities | 11,336 | 9,753 | 9,199 |
| Current liabilities | |||
| Current interest-bearing liabilities | – | – | – |
| Commercial paper | 1,125 | 758 | 1,039 |
| Lease liabilities | 1,317 | 1,105 | 1,138 |
| Accounts payable | 360 | 283 | 403 |
| Other provisions | 8 | 2 | 76 |
| Tax liabilities | 139 | 137 | 127 |
| Other non-interest-bearing liabilities | 173 | 153 | 180 |
| Accrued expenses and deferred income | 1,391 | 1,211 | 1,327 |
| Total current liabilities | 4,513 | 3,649 | 4,290 |
| Total equity and liabilities | 21,208 | 18,176 | 18,475 |

| SEK million | 2025 Jan–Sep |
2024 Jan–Sep |
2024 Jan–Dec |
|---|---|---|---|
| Opening balance | 4,986 | 4,920 | 4,920 |
| Comprehensive income | 544 | 415 | 603 |
| New share issue | 14 | – | 23 |
| Warrants issued | – | – | 1 |
| Share buybacks | −220 | −431 | −431 |
| Exercise of repurchased shares | 220 | – | – |
| Dividends | −185 | −130 | −130 |
| Closing balance | 5,359 | 4,774 | 4,986 |
| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating activities | ||||||
| Operating profit | 538 | 455 | 1,077 | 958 | 1,397 | 1,278 |
| Depreciation, amortisation and impairment | 392 | 343 | 1,110 | 1,022 | 1,455 | 1,367 |
| Capital gains/losses | −4 | −3 | −7 | −9 | −18 | −20 |
| Changes in provisions | 1 | −17 | −6 | −37 | −30 | −61 |
| Total non-cash items | 389 | 323 | 1,097 | 976 | 1,407 | 1,286 |
| Net interest paid | −123 | −116 | −378 | −353 | −492 | −467 |
| Tax paid | −70 | −24 | −164 | −84 | −218 | −138 |
| Cash flow from operating activities before changes in work | ||||||
| ing capital | 734 | 638 | 1,632 | 1,497 | 2,094 | 1,959 |
| Cash flow from changes in working capital | ||||||
| Decrease/increase in receivables | 2 | 98 | −96 | 8 | –74 | 30 |
| Decrease/increase in current liabilities | −242 | −336 | −281 | −185 | −19 | 77 |
| Cash flow from operating activities | 494 | 400 | 1,255 | 1,320 | 2,001 | 2,066 |
| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Investing activities | ||||||
| Acquisition of tangible assets | −22 | −15 | −90 | −64 | −131 | −105 |
| Acquisition of intangible assets | −4 | −1 | −10 | −10 | −12 | −12 |
| Sale of fixed assets | 15 | 1 | 16 | 13 | 20 | 17 |
| Acquisition of subsidiaries | 2 | −18 | –1,175 | −90 | –1,338 | −253 |
| Investments in financial instruments | −1 | −6 | −3 | −6 | −2 | −5 |
| Cash flow from investing activities | −10 | −39 | –1,262 | −157 | –1,463 | −358 |
| Cash flow after investments | 484 | 361 | −6 | 1,163 | 539 | 1,708 |
| Financing activities Loans raised Repayment of debt Repayment of lease liabilities |
1,174 –1,046 −316 |
956 −772 −273 |
4,320 –3,231 −904 |
2,226 –2,207 −815 |
5,581 –4,231 –1,181 |
3,487 –3,207 –1,092 |
| Net change in checking account | −283 | −123 | 442 | 230 | −126 | −338 |
| New share issue Cost of loans raised |
– – |
– – |
14 −1 |
– – |
37 −1 |
23 – |
| Premiums for warrants | – | – | – | 1 | – | 1 |
| Share buybacks | – | −146 | −219 | −431 | −219 | −431 |
| Dividends paid | – | – | −185 | −130 | −185 | −130 |
| Cash flow from financing activities | −471 | −358 | 236 | –1,126 | −325 | –1,687 |
| Cash flow for the period | 13 | 3 | 229 | 37 | 213 | 21 |
| Cash and cash equivalents on the opening date | 247 | 39 | 28 | 6 | 45 | 6 |
| Exchange rate differences in cash and cash equivalents | −1 | 3 | 2 | 2 | 1 | 1 |
| Cash and cash equivalents on the closing date | 259 | 45 | 259 | 45 | 259 | 28 |


| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating income | ||||||
| Other operating income | 0 | 0 | 23 | 0 | 23 | 0 |
| Operating income | 0 | 0 | 23 | 0 | 23 | 0 |
| Operating expenses | ||||||
| Other external costs | −4 | −4 | −40 | −14 | –43 | −17 |
| Personnel costs | −3 | −3 | −12 | −12 | −16 | −16 |
| Amortisation of intangible assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating expenses | −7 | −7 | −52 | −26 | −59 | −33 |
| Operating profit/loss | −7 | −7 | −29 | −26 | –36 | −33 |
| Financial items | −18 | −40 | −30 | −77 | −47 | −84 |
| Profit/loss after financial items | −25 | −47 | −69 | −103 | −83 | −117 |
| Appropriations | – | – | – | – | 179 | 179 |
| Profit/loss before tax | −25 | −47 | −69 | −103 | 96 | 62 |
| Tax on profit for the period | – | – | – | – | −19 | −19 |
| Profit/loss for the period | −25 | −47 | −69 | −103 | 77 | 43 |

| SEK million | 2025 30 Sep |
2024 30 Sep |
2024 31 Dec |
|---|---|---|---|
| Assets | |||
| Fixed assets | |||
| Intangible assets | 0 | 0 | 0 |
| Financial assets | |||
| Participations in Group companies | 7,432 | 7,212 | 7,212 |
| Receivables from Group companies | 577 | 589 | 595 |
| Derivative instruments | 2 | 6 | 5 |
| Total fixed assets | 8,011 | 7,807 | 7,812 |
| Current assets | |||
| Receivables from Group companies | 4,524 | 3,439 | 3,844 |
| Other receivables | 47 | 22 | 26 |
| Prepaid expenses and accrued income | 11 | 14 | 13 |
| Cash and cash equivalents | – | 7 | – |
| Total current assets | 4,582 | 3,482 | 3,883 |
| Total assets | 12,593 | 11,289 | 11,695 |
| SEK million | 2025 30 Sep |
2024 30 Sep |
2024 31 Dec |
|---|---|---|---|
| Equity and liabilities | |||
| Equity | |||
| Restricted equity | |||
| Share capital | 2 | 2 | 2 |
| Statutory reserve | 0 | 0 | 0 |
| Total restricted equity | 2 | 2 | 2 |
| Non-restricted equity | |||
| Share premium reserve | 1,443 | 1,406 | 1,429 |
| Retained earnings | 699 | 842 | 842 |
| Profit/loss for the period | −69 | −103 | 43 |
| Total non-restricted equity | 2,073 | 2,145 | 2,314 |
| Total equity | 2,075 | 2,147 | 2,316 |
| Untaxed reserves | 117 | 85 | 117 |
| Non-current liabilities | |||
| Liabilities to credit institutions | 2,580 | 1,686 | 1,125 |
| Total non-current liabilities | 2,580 | 1,686 | 1,125 |
| Current liabilities | |||
| Commercial paper | 1,125 | 758 | 1,037 |
| Accounts payable | – | – | 9 |
| Tax liabilities | 19 | −1 | 19 |
| Liabilities to Group companies | 6,664 | 6,594 | 7,054 |
| Other liabilities | 0 | 0 | 0 |
| Accrued expenses and deferred income | 13 | 20 | 18 |
| Total current liabilities | 7,821 | 7,371 | 8,137 |
| Total equity and liabilities | 12,593 | 11,289 | 11,695 |

This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting and the Swedish Annual Accounts Act, as well as the Swedish Financial Reporting Board's RFR 1, Supplementary Accounting Rules for Groups, and RFR 2 Accounting for Legal Entities. The accounting policies applied are consistent with those applied in the preparation of the most recent annual report. Since all amounts are rounded, rounding differences can occur.
None of the new or revised standards or interpretations effective from 1 January 2025 had any material impact on the financial statements of the Group or the Parent Company. No new or revised standards have been adopted in advance.
Ambea's operations consist of the following segments:
| SEK million | 2025 Q3 |
2025 Q2 |
2025 Q1 |
2024 Q4 |
2024 Q3 |
2024 Q2 |
2024 Q1 |
2023 Q4 |
2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | |||||||||
| Nytida | 1,148 | 1,150 | 1,122 | 1,108 | 1,056 | 1,044 | 1,041 | 1,018 | 1,005 |
| Vardaga | 1,381 | 1,358 | 1,313 | 1,306 | 1,288 | 1,262 | 1,231 | 1,200 | 1,159 |
| Stendi | 818 | 823 | 823 | 834 | 841 | 840 | 837 | 808 | 806 |
| Validia | 388 | 375 | – | – | – | – | – | – | – |
| Altiden | 341 | 327 | 333 | 329 | 320 | 311 | 313 | 317 | 326 |
| Klara | 86 | 104 | 100 | 106 | 94 | 104 | 105 | 116 | 106 |
| Group adjustments | –48 | −49 | −47 | −46 | −44 | −42 | –43 | –47 | –47 |
| Ambea | 4,114 | 4,088 | 3,644 | 3,637 | 3,555 | 3,519 | 3,484 | 3,412 | 3,355 |
| Adjusted EBITA Nytida |
194 | 127 | 118 | 121 | 168 | 124 | 125 | 130 | 168 |
| Vardaga | 177 | 115 | 111 | 122 | 161 | 105 | 103 | 88 | 123 |
| Stendi | 100 | 29 | 68 | 93 | 121 | 61 | 59 | 70 | 88 |
| Validia | 59 | 39 | – | – | – | – | – | – | – |
| Altiden | 39 | 1 | 8 | 10 | 25 | −13 | −9 | –14 | –2 |
| Klara | 9 | 9 | 8 | 11 | 10 | 5 | 9 | 14 | 14 |
| Unallocated items | −8 | −9 | −6 | −13 | −7 | −11 | –8 | –11 | –8 |
| Ambea | 570 | 311 | 307 | 344 | 478 | 271 | 279 | 286 | 383 |

| SEK million Nytida Vardaga Stendi Validia Altiden Klara items adjustments Group Operating income Net sales 1,148 1,381 818 388 341 86 – –48 4,114 Other operating income 6 21 1 0 2 0 0 – 30 Total income 1,154 1,402 819 388 342 86 0 –48 4,144 EBITA 194 177 100 59 39 9 −13 – 565 EBITA margin, % 16.9 12.8 12.2 15.2 11.4 10.5 – – 13.7 Items affecting comparability – – – – – – 5 – 5 Adjusted EBITA 194 177 100 59 39 9 −8 – 570 Adjusted EBITA margin, % 16.9 12.8 12.2 15.2 11.4 10.5 – – 13.8 Amortisation of intangible assets −26 Operating profit (EBIT) 539 Net financial items −126 Profit before tax 413 Tax on profit for the period −91 Profit for the period 322 Assets 6,955 7,521 2,087 2,437 1,360 301 547 – 21,208 July–September 2024 Unallocated Group SEK million Nytida Vardaga Stendi Validia Altiden Klara items adjustments Group Operating income Net sales 1,056 1,288 841 – 320 94 0 −44 3,555 Other operating income 8 20 2 – 4 1 0 0 35 Total income 1,064 1,308 843 – 324 95 0 −44 3,590 EBITA 168 161 121 – 25 10 −7 0 478 EBITA margin, % 15.9 12.5 14.4 – 7.8 10.6 – – 13.4 Items affecting comparability – – – – – – – – – Adjusted EBITA 168 161 121 – 25 10 −7 0 478 Adjusted EBITA margin, % 15.9 12.5 14.4 – 7.8 10.6 – – 13.4 Amortisation of intangible assets −23 Operating profit (EBIT) 455 Net financial items −118 Profit before tax 337 Tax on profit for the period −71 Profit for the period 266 Assets 6,684 7,613 1,931 – 1,461 306 181 – 18,176 |
July–September 2025 | ||||||
|---|---|---|---|---|---|---|---|
| Unallocated | Group | ||||||
*The 'Unallocated items' column consists of centrally approved costs

| January–September 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| SEK million | Nytida | Vardaga | Stendi | Validia | Altiden | Klara | Unallocated items* |
Group adjustments |
Group |
| Operating income | |||||||||
| Net sales | 3,420 | 4,052 | 2,464 | 763 | 1,001 | 290 | – | −144 | 11,846 |
| Other operating income | 19 | 75 | 2 | 1 | 4 | 1 | 5 | – | 107 |
| Total income | 3,439 | 4,127 | 2,466 | 764 | 1,005 | 291 | 5 | −144 | 11,953 |
| EBITA | 439 | 402 | 198 | 98 | 48 | 26 | −83 | – | 1,128 |
| EBITA margin (%) | 12.8 | 9.9 | 8.0 | 12.8 | 4.8 | 9.0 | – | – | 9.5 |
| Items affecting comparability | – | – | – | – | – | – | 60 | – | 60 |
| Adjusted EBITA | 439 | 402 | 198 | 98 | 48 | 26 | −23 | – | 1,188 |
| Adjusted EBITA margin, % | 12.8 | 9.9 | 8.0 | 12.8 | 4.8 | 9.0 | – | – | 10.0 |
| Amortisation of intangible assets | −51 | ||||||||
| Operating profit (EBIT) | 1,077 | ||||||||
| Net financial items | −376 | ||||||||
| Profit before tax | 701 | ||||||||
| Tax on profit for the period | −166 | ||||||||
| Profit for the period | 535 | ||||||||
| Assets | 6,955 | 7,521 | 2,087 | 2,437 | 1,360 | 301 | 547 | – | 21,208 |
| January–September 2024 | Unallocated | Group | |||||||
| SEK million | Nytida | Vardaga | Stendi | Validia | Altiden | Klara | items* | adjustments | Group |
| Operating income | |||||||||
| Net sales | 3,141 | 3,781 | 2,518 | – | 944 | 303 | – | −129 | 10,558 |
| Other operating income | 29 | 62 | 7 | – | 16 | 1 | 4 | – | 119 |
| Total income | 3,170 | 3,843 | 2,525 | – | 960 | 304 | 4 | −129 | 10,677 |
| EBITA | 417 | 369 | 241 | – | 3 | 24 | −27 | 0.0 | 1,028 |
| EBITA margin (%) | 13.3 | 9.8 | 9.6 | – | 0.3 | 7.9 | – | – | 9.7 |
| Items affecting comparability | – | – | – | – | – | – | – | – | – |
| Adjusted EBITA | 417 | 369 | 241 | – | 3 | 24 | −27 | 0.0 | 1,028 |
| Adjusted EBITA margin, % | 13.3 | 9.8 | 9.6 | – | 0.3 | 7.9 | – | – | 9.7 |
| Amortisation of intangible assets | −70 | ||||||||
| Operating profit (EBIT) | 958 | ||||||||
| Net financial items | −352 | ||||||||
| Profit before tax | 606 | ||||||||
| Tax on profit for the period | −135 | ||||||||
Profit for the period 471 Assets 6,684 7,613 1,931 – 1,461 306 181 – 18,176
*The 'Unallocated items' column consists of centrally approved costs

| Nytida | Vardaga | Stendi | Validia | Altiden | Klara | Group eliminations |
Group | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEK million | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
| Own Management | 923 | 850 | 952 | 882 | 818 | 841 | 388 | – | 253 | 230 | – | – | – | – | 3,334 | 2,803 |
| Contract Management | 225 | 206 | 429 | 406 | 0 | – | 0 | – | 88 | 90 | – | – | – | – | 742 | 702 |
| Competence and staffing solutions | – | – | – | – | – | – | – | – | – | – | 86 | 94 | –48 | −44 | 38 | 50 |
| Total | 1,148 | 1,056 | 1,381 | 1,288 | 818 | 841 | 388 | – | 341 | 320 | 86 | 94 | –48 | −44 | 4,114 | 3,555 |
| Income | ||||||||||||||||
| External customers | 1,148 | 1,056 | 1,381 | 1,288 | 818 | 841 | 388 | – | 341 | 320 | 38 | 50 | – | – | 4,114 | 3,555 |
| Revenue between segments | – | – | – | – | – | – | – | – | – | – | 48 | 44 | –48 | −44 | – | – |
| Total | 1,148 | 1,056 | 1,381 | 1,288 | 818 | 841 | 388 | – | 341 | 320 | 86 | 94 | –48 | −44 | 4,114 | 3,555 |
| Nytida | Vardaga | Stendi | Validia | Altiden | Klara | Group eliminations |
Group | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEK million | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
| Own Management | 2,763 | 2,525 | 2,782 | 2,591 | 2,464 | 2,484 | 763 | – | 740 | 672 | – | – | – | – | 9,512 | 8,271 |
| Contract Management | 657 | 616 | 1,270 | 1,190 | 0 | 34 | 0 | – | 261 | 272 | – | – | – | – | 2,188 | 2,113 |
| Competence and staffing solutions | – | – | – | – | – | – | – | – | – | – | 290 | 303 | −144 | −129 | 146 | 174 |
| Total | 3,420 | 3,141 | 4,052 | 3,781 | 2,464 | 2,518 | 763 | – | 1,001 | 944 | 290 | 303 | −144 | −129 | 11,846 | 10,558 |
| Income | ||||||||||||||||
| External customers | 3,420 | 3,141 | 4,052 | 3,781 | 2,464 | 2,518 | 763 | – | 1,001 | 944 | 146 | 174 | – | – | 11,846 | 10,558 |
| Revenue between segments | – | – | – | – | – | – | – | – | – | – | 144 | 129 | −144 | −129 | – | – |
| Total | 3,420 | 3,141 | 4,052 | 3,781 | 2,464 | 2,518 | 763 | – | 1,001 | 944 | 290 | 303 | −144 | −129 | 11,846 | 10,558 |

| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Acquisition-related costs | 5 | – | 60 | – | 60 | – |
| Total items affecting comparability | 5 | – | 60 | – | 60 | – |
On 1 April, Validia Oy was acquired, which operates residential care and support for people with disabilities in Finland. The acquisition includes approximately 50 care units, 1,400 care places and 2,600 employees. The consideration amounted to SEK 1,440 million, of which SEK 220 million was paid in own shares. Transaction costs in connection with the acquisition amounted to SEK 55 million as of 30 September, and was recognised as other external costs affecting comparability. The amounts are based on the exchange rate on 1 April, EUR/SEK 10.8160. Since the acquisition date, Validia has contributed SEK 763 million to net sales, and SEK 92 million to profit before tax. If the acquisition had taken place on 1 January 2025, Validia would have contributed SEK 1,128 million to net sales and SEK 125 million to profit before tax.
On 5 May, parts of the care provider AvAsta were acquired. The acquisition comprises the Sisjödal nursing home as well as AvAsta's four care homes providing care for adults with lifelong disabilities and social problems. The consideration amounted to SEK 119 million. Transaction costs in connection with the acquisition amounted to SEK 2 million, and was recognised as other external costs. The acquisition analysis is preliminary as some work remains before it is completed. Since the acquisition date, the companies have contributed SEK 64 million to net sales and SEK 7 million to profit before tax. If the acquisition had taken place on 1 January 2025, the companies would have contributed SEK 112 million to net sales and SEK 11 million to profit before tax.
| SEK million | Validia | AvAsta | Total |
|---|---|---|---|
| The carrying amount of net identifiable assets excl. intangible assets |
164 | 10 | 174 |
| Intangible assets | 260 | 15 | 275 |
| Group goodwill | 1,017 | 94 | 1,111 |
| Total consideration (price of shares) | 1,440 | 119 | 1,559 |
| Less: cash and cash equivalents | −140 | −25 | −165 |
| Less: payment with own shares | −220 | – | −220 |
| Net change in cash | 1,080 | 94 | 1,174 |
| SEK million | Validia | AvAsta | Total |
|---|---|---|---|
| Fixed assets | 115 | 4 | 119 |
| Right-of-use assets | 919 | 239 | 1,158 |
| Accounts receivable and other receivables | 149 | 39 | 188 |
| Cash and cash equivalents | 140 | 25 | 165 |
| Non-current liabilities and provisions | 0 | 0 | 0 |
| Deferred tax liability | −56 | −3 | −59 |
| Lease liabilities | −919 | −239 | –1,158 |
| Accounts payable and other liabilities | −184 | −55 | −240 |
| Net identifiable assets | 164 | 10 | 174 |
| Date | Acquisition | Operations | Segments | Annual sales |
|---|---|---|---|---|
| 1 Apr 2025 | Validia | Residential care and support for people with disabilities | Validia | SEK 1,395 million |
| 5 May 2025 | AvAsta | Elderly care, residential care and support for people with disabilities | Nytida and Vardaga | SEK 144 million |

| Classification in the fair value hierarchy | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||||
| SEK million | 2025 30 Sep |
2024 30 Sep |
2025 30 Sep |
2024 30 Sep |
2025 30 Sep |
2024 30 Sep |
2025 30 Sep |
2024 30 Sep |
| Assets | ||||||||
| Interest-rate derivatives | 4 | – | – | – | 4 | – | – | – |
| Investments in housing coopera tive associations |
88 | 88 | – | – | – | – | 88 | 88 |
| Total | 92 | 88 | – | – | 4 | – | 88 | 88 |
| Liabilities | ||||||||
| Interest-rate derivatives | – | 1 | – | – | – | 1 | – | – |
| Contingent consideration | – | 2 | – | – | – | – | – | 2 |
| Total | – | 3 | – | – | – | 1 | – | 2 |
Ambea applies the following hierarchy for the fair value measurement of financial instruments:
Ambea has borrowings/loans in Swedish, Norwegian and Danish kronor and is thereby exposed to interest-rate risk. According to the company's Financial Policy, at least 50 per cent of the interest-rate risk should be hedged. To reduce the company's interest-rate risk, the company uses different types of interest-rate hedging products (interest-rate derivatives). The hedges have a remaining term of up to three years. In total, about 59 per cent of the company's average interest-bearing liabilities within 12 months have been hedged with interest-rate derivatives.
Derivatives are classified as Level 2 assets in the fair value hierarchy. The change in fair value of the interest-rate cap and interest-rate swap was recognised in other comprehensive income. Ambea uses standard bank pricing models for the valuation of purchased interest-rate caps and interest-rate swaps. The valuation is based on the bank's standard pricing model and methodology. The valuation is based on the bank's average price.
There have been no changes between the levels since the most recent annual report.
| SEK million | 2025 30 Sep |
2024 30 Sep |
2024 31 Dec |
|---|---|---|---|
| Tax dispute | 14 | 14 | 14 |
| Total contingent liabilities | 14 | 14 | 14 |

| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Growth/Acquired growth | ||||||
| Net sales growth (%) | 15.7 | 6.0 | 12.2 | 6.6 | 10.8 | 6.6 |
| Of which organic growth (%) | 3.5 | 7.2 | 4.2 | 6.9 | 4.5 | 6.5 |
| Of which acquired/divested growth (%) | 13.2 | 0.6 | 9.4 | 0.2 | 7.5 | 0.5 |
| Of which currency and calendar effect (%) | −1.0 | −1.8 | −1.4 | −0.5 | −1.2 | −0.4 |
| Operating margin (EBIT) | ||||||
| Net sales | 4,114 | 3,555 | 11,846 | 10,558 | 15,483 | 14,195 |
| Operating profit (EBIT) | 539 | 455 | 1,077 | 958 | 1,397 | 1,278 |
| Operating margin, EBIT (%) | 13.1 | 12.8 | 9.1 | 9.1 | 9.0 | 9.0 |
| EBITA and adjusted EBITA | ||||||
| Operating profit (EBIT) | 539 | 455 | 1,077 | 958 | 1,397 | 1,278 |
| Amortisation and impairment of intangible assets | 26 | 23 | 51 | 70 | 75 | 94 |
| EBITA | 565 | 478 | 1,128 | 1,028 | 1,472 | 1,372 |
| Items affecting comparability | 5 | – | 60 | – | 60 | – |
| Adjusted EBITA | 570 | 478 | 1,188 | 1,028 | 1,532 | 1,372 |
| Net sales | 4,114 | 3,555 | 11,846 | 10,558 | 15,483 | 14,195 |
| EBITA margin (%) | 13.7 | 13.4 | 9.5 | 9.7 | 9.5 | 9.7 |
| Adjusted EBITA margin, % | 13.9 | 13.4 | 10.0 | 9.7 | 9.9 | 9.7 |
| EBITDA and adjusted EBITDA | ||||||
| Operating profit (EBIT) | 539 | 455 | 1,077 | 958 | 1,397 | 1,278 |
| Depreciation, amortisation and impairment of tangible and intangible assets |
392 | 343 | 1,110 | 1,022 | 1,455 | 1,367 |
| EBITDA | 931 | 798 | 2,187 | 1,980 | 2,852 | 2,645 |
| Items affecting comparability | 5 | – | 60 | – | 60 | – |
| Adjusted EBITDA | 936 | 798 | 2,247 | 1,980 | 2,912 | 2,645 |
| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| EBITDA and adjusted EBITDA, excluding IFRS 16 effects | ||||||
| Operating profit (EBIT) | 539 | 455 | 1,077 | 958 | 1,397 | 1,278 |
| Depreciation, amortisation and impairment of tangible and intangible assets |
392 | 343 | 1,110 | 1,022 | 1,455 | 1,367 |
| Less: Rental payments, Properties | −383 | −336 | –1,103 | −997 | –1,438 | –1,332 |
| Less: Rental payments, Vehicles | −20 | −18 | −58 | −52 | −77 | −71 |
| Less Capital loss from contracts terminated | −1 | −2 | −4 | −4 | −5 | −5 |
| Net effects of IFRS 16 on EBITDA | −404 | −356 | –1,165 | –1,053 | –1,520 | –1,408 |
| EBITDA excluding IFRS 16 effects | 527 | 442 | 1,022 | 927 | 1,332 | 1,237 |
| Items affecting comparability | 5 | – | 60 | – | 60 | – |
| Adjusted EBITDA excluding IFRS 16 effects | 532 | 442 | 1,082 | 927 | 1,392 | 1,237 |
| EBITA and adjusted EBITA, excluding IFRS 16 effects | ||||||
| Operating profit (EBIT) | 539 | 455 | 1,077 | 958 | 1,397 | 1,278 |
| Amortisation and impairment of intangible assets | 26 | 23 | 51 | 70 | 75 | 94 |
| EBITA | 565 | 478 | 1,128 | 1,028 | 1,472 | 1,372 |
| Plus IFRS 16 depreciation | 338 | 296 | 980 | 883 | 1,277 | 1,180 |
| Less: Rental payments, Properties | −383 | −336 | –1,103 | −997 | –1,438 | –1,332 |
| Less: Rental payments, Vehicles | −20 | −18 | −58 | −52 | −77 | −71 |
| Less Capital loss from contracts terminated | −1 | −2 | −4 | −4 | −5 | −5 |
| Net effects of IFRS 16 on EBITA | −66 | −60 | −185 | −170 | −243 | −228 |
| EBITA excluding IFRS 16 effects | 499 | 418 | 943 | 857 | 1,230 | 1,144 |
| Items affecting comparability | 5 | – | 60 | – | 60 | – |
| Adjusted EBITA excluding IFRS 16 effects | 504 | 418 | 1,003 | 857 | 1,290 | 1,144 |
| EBITA margin, excluding IFRS 16 effects | 12.1 | 11.8 | 8.0 | 8.1 | 7.9 | 8.1 |
| Adjusted EBITA margin, excluding IFRS 16 effects | 12.3 | 11.8 | 8.5 | 8.1 | 8.3 | 8.1 |

| SEK million | 2025 Jul–Sep |
2024 Jul–Sep |
2025 Jan–Sep |
2024 Jan–Sep |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating cash flow | ||||||
| EBITDA | 930 | 798 | 2,187 | 1,980 | 2,852 | 2,645 |
| Adjustment for non-cash items | −2 | −20 | −13 | −47 | −47 | −81 |
| Cash flow from investing activities excl. acquisitions and investments in financial instruments |
−13 | −15 | −87 | −61 | −126 | −100 |
| Adjustment for cash flow from investing activities related to increased capacity/growth |
11 | 2 | 11 | 18 | 12 | 19 |
| Change in working capital | −240 | −238 | −377 | −177 | −93 | 107 |
| Operating cash flow | 686 | 527 | 1,721 | 1,713 | 2,598 | 2,590 |
| Cash conversion (%) Operating cash flow |
686 | 527 | 1,721 | 1,713 | 2,598 | 2,590 |
| EBITDA | 931 | 798 | 2,187 | 1,980 | 2,852 | 2,645 |
| Cash conversion (%) | 73.7 | 66.0 | 78.7 | 86.5 | 91.1 | 97.9 |
| Items affecting comparability Reversal of acquisition-related costs |
||||||
| – of which costs included in the line item of other external costs | 5 | – | 60 | – | 60 | – |
| Total acquisition-related costs | 5 | – | 60 | – | 60 | – |
| Total items affecting comparability | 5 | – | 60 | – | 60 | – |
| SEK million | 2025 30 Sep |
2024 30 Sep |
2024 31 Dec |
|---|---|---|---|
| Net debt, Net debt/Adjusted EBITDA, RTM | |||
| Non-current interest-bearing liabilities | 10,950 | 9,404 | 8,878 |
| Current interest-bearing liabilities | 2,442 | 1,863 | 2,177 |
| Less: cash and cash equivalents | −259 | –45 | −28 |
| Net debt | 13,133 | 11,222 | 11,027 |
| Adjusted EBITDA RTM | 2,912 | 2,571 | 2,645 |
| Net debt/Adjusted EBITDA, RTM (times) | 4.5 | 4.4 | 4.2 |
| Net debt, Net debt/Adjusted EBITDA, RTM, excl. IFRS 16 effects | |||
| Non-current interest-bearing liabilities Less: non-current lease liabilities pertaining to properties, recognised on the lease liabilities line |
10,950 –8,251 |
9,404 –7,565 |
8,878 –7,568 |
| Less: non-current lease liabilities pertaining to vehicles, recognised on the lease liabilities line | −177 | −186 | −223 |
| Current interest-bearing liabilities | 2,442 | 1,863 | 2,177 |
| Less: current lease liabilities pertaining to properties recognised on the lease liabilities line | –1,202 | –1,035 | –1,062 |
| Less: current lease liabilities pertaining to vehicles, recognised on the lease liabilities line | −114 | −70 | −76 |
| Less: cash and cash equivalents | −259 | –45 | −28 |
| Net debt, excluding IFRS 16 effects | 3,389 | 2,356 | 2,098 |
| Adjusted EBITDA RTM | 1,392 | 1,178 | 1,237 |
| Net debt/Adjusted EBITDA, RTM (times) | 2.4 | 2.0 | 1.7 |

The IVO conducted 14 quality inspections in Nytida and none in Vardaga. During the quarter, the IVO issued decisions in 12 quality inspections at Nytida, one of which resulted in remarks. No decisions were issued in Vardaga during the quarter.
Lex Sarah reports: A total of six Lex Sarah reports were lodged, four by Nytida and two by Vardaga. Five decisions have been issued and all were closed without any remarks.
Lex Maria reports: Two Lex Maria reports were lodged in Sweden. One in Nytida and one in Vardaga. During the quarter, three decisions were issued with regard to previous reports, all of which were closed without any remarks.
Individual complaints investigated by the IVO: A total of three individual complaints were lodged during the quarter. Two in Vardaga and one in Nytida. The IVO has closed an older complaint (from 2023), and the case was closed without any remarks.
Regulatory inspections based on quality management: A total of 31 quality inspections were performed in Norway during the quarter. 29 of these pertained to services for children and two to care services for adults. Two of the quality inspections resulted in remarks, both in services for children.
A total of five quality inspections were performed in Validia's operations, all of which in the wellbeing services counties. While all of these quality inspections contained remarks, none of the discrepancies were deemed to be serious.
Regulatory inspections based on quality management: At Altiden, 19 quality inspections were completed, three in elderly care and 16 in social care. A total of 18 decisions were received in the quarter. Only one of the quality inspections resulted in remarks.
The Swedish Data Protection Officer notified the IMY of four personal data breaches during the third quarter. During the quarter, we also received five decisions on previous notifications, for which the IMY is not taking any measures. None of them posed, or were deemed to pose, a serious risk to the data subjects. In all cases, relevant measures were taken immediately to prevent any recurrence by raising awareness and competence in regard to existing procedures and work processes.
No reports were made to the Norwegian Data Protection Authority and one report was made to the Danish Data Protection Agency.
A report was made to the Office of the Data Protection Ombudsman in Finland, but no action is being taken.
(IVO):The IVO is a government agency responsible for supervising social care in Sweden, including healthcare and social services. The agency's mission is to ensure that elderly and social care maintains high quality and is provided in accordance with legislation. The agency is also responsible for issuing permits to private care providers.
Lex Sarah: A reporting obligation in social services and under LSS (Act on Support and Service to Persons with Certain Functional Disabilities) entailing that employees are obligated to report serious misconduct or risks of such misconduct. These reports are made to the IVO, with the aim of improving the quality of the operations and protecting the rights of the individual.
Lex Maria: A reporting obligation in healthcare that requires care providers to report incidents that have caused, or could have caused, serious injury to a patient. These reports are made to the IVO, with the aim of improving patient safety through systematic measures.
The Swedish Authority for Privacy Protection (IMY): The IMY reviews and enforces the application of data protection rules, including the GDPR. The agency works with issues related to data protection and has been tasked with strengthening the privacy rights of individuals in digital environments.
We make the world a better place, one person at a time.
Have a question? We'll get back to you promptly.